
Anthony R. Shumate
Examiner (ID: 9454, Phone: (571)270-5546 , Office: P/1773 )
| Most Active Art Unit | 1776 |
| Art Unit(s) | 1772, 1776, 1775, 1773, 1797 |
| Total Applications | 1063 |
| Issued Applications | 781 |
| Pending Applications | 73 |
| Abandoned Applications | 233 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 17140164
[patent_doc_number] => 20210308175
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-10-07
[patent_title] => Systems And Methods To Improve Organ Or Tissue Function And Organ Or Tissue Transplant Longevity
[patent_app_type] => utility
[patent_app_number] => 17/349425
[patent_app_country] => US
[patent_app_date] => 2021-06-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13382
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17349425
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/349425 | Systems And Methods To Improve Organ Or Tissue Function And Organ Or Tissue Transplant Longevity | Jun 15, 2021 | Abandoned |
Array
(
[id] => 17554831
[patent_doc_number] => 11311488
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-04-26
[patent_title] => Osmotic dosage forms comprising deutetrabenazine and methods of use thereof
[patent_app_type] => utility
[patent_app_number] => 17/344271
[patent_app_country] => US
[patent_app_date] => 2021-06-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 16678
[patent_no_of_claims] => 28
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 202
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17344271
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/344271 | Osmotic dosage forms comprising deutetrabenazine and methods of use thereof | Jun 9, 2021 | Issued |
Array
(
[id] => 18523166
[patent_doc_number] => 20230233821
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-07-27
[patent_title] => INGESTIBLE DEVICE HAVING A SPIKE ASSEMBLY
[patent_app_type] => utility
[patent_app_number] => 18/009173
[patent_app_country] => US
[patent_app_date] => 2021-06-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10091
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 414
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18009173
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/009173 | INGESTIBLE DEVICE HAVING A SPIKE ASSEMBLY | Jun 9, 2021 | Abandoned |
Array
(
[id] => 18522810
[patent_doc_number] => 20230233459
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-07-27
[patent_title] => ANATABINE POWDER COMPOSITIONS
[patent_app_type] => utility
[patent_app_number] => 18/008793
[patent_app_country] => US
[patent_app_date] => 2021-05-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10907
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 41
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18008793
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/008793 | ANATABINE POWDER COMPOSITIONS | May 27, 2021 | Pending |
Array
(
[id] => 18468727
[patent_doc_number] => 20230203009
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-06-29
[patent_title] => PRALSETINIB PHARMACEUTICAL COMPOSITIONS
[patent_app_type] => utility
[patent_app_number] => 18/000166
[patent_app_country] => US
[patent_app_date] => 2021-05-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 19050
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -121
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18000166
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/000166 | PRALSETINIB PHARMACEUTICAL COMPOSITIONS | May 27, 2021 | Pending |
Array
(
[id] => 18619163
[patent_doc_number] => 11752185
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-09-12
[patent_title] => Powderized cannabis oil
[patent_app_type] => utility
[patent_app_number] => 17/333258
[patent_app_country] => US
[patent_app_date] => 2021-05-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 4673
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 62
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17333258
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/333258 | Powderized cannabis oil | May 27, 2021 | Issued |
Array
(
[id] => 20491465
[patent_doc_number] => 12533320
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2026-01-27
[patent_title] => Oral sustained-release composition for insoluble drug, and preparation method thereof
[patent_app_type] => utility
[patent_app_number] => 18/005179
[patent_app_country] => US
[patent_app_date] => 2021-05-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 3971
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 317
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18005179
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/005179 | Oral sustained-release composition for insoluble drug, and preparation method thereof | May 24, 2021 | Issued |
Array
(
[id] => 17080454
[patent_doc_number] => 20210275460
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-09-09
[patent_title] => ORAL PHARMACEUTICAL COMPOSITION WITH A PLANT ALKALOID FOR TREATMENT OF DEPENDENCIES
[patent_app_type] => utility
[patent_app_number] => 17/328911
[patent_app_country] => US
[patent_app_date] => 2021-05-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3452
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -5
[patent_words_short_claim] => 149
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17328911
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/328911 | Oral pharmaceutical composition with a plant alkaloid for treatment of dependencies | May 23, 2021 | Issued |
Array
(
[id] => 18389744
[patent_doc_number] => 20230157962
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-05-25
[patent_title] => NOVEL EXTENDED RELEASE COMPOSITION OF 2-(2- AMINOTHIAZOL-4-YL)-N-[4-(2{[(2R)-2-HYDROXY-2-PHENYLETHYL] AMINO} ETHYL) PHENYL] ACETAMIDE
[patent_app_type] => utility
[patent_app_number] => 17/922914
[patent_app_country] => US
[patent_app_date] => 2021-05-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5218
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -8
[patent_words_short_claim] => 18
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17922914
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/922914 | NOVEL EXTENDED RELEASE COMPOSITION OF 2-(2- AMINOTHIAZOL-4-YL)-N-[4-(2{[(2R)-2-HYDROXY-2-PHENYLETHYL] AMINO} ETHYL) PHENYL] ACETAMIDE | May 14, 2021 | Pending |
Array
(
[id] => 19232034
[patent_doc_number] => 20240189225
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-06-13
[patent_title] => COMPOSITIONS AND METHODS FOR HARDENING
[patent_app_type] => utility
[patent_app_number] => 17/998689
[patent_app_country] => US
[patent_app_date] => 2021-05-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 21115
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17998689
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/998689 | COMPOSITIONS AND METHODS FOR HARDENING | May 13, 2021 | Pending |
Array
(
[id] => 18404499
[patent_doc_number] => 20230165850
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-06-01
[patent_title] => NEW COMPOSITIONS FOR ORAL OR NASAL USE
[patent_app_type] => utility
[patent_app_number] => 17/922623
[patent_app_country] => US
[patent_app_date] => 2021-05-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5368
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -20
[patent_words_short_claim] => 67
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17922623
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/922623 | NEW COMPOSITIONS FOR ORAL OR NASAL USE | May 6, 2021 | Pending |
Array
(
[id] => 18466843
[patent_doc_number] => 20230201123
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-06-29
[patent_title] => PHARMACEUTICAL COMPOSITION
[patent_app_type] => utility
[patent_app_number] => 17/998863
[patent_app_country] => US
[patent_app_date] => 2021-05-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8460
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -28
[patent_words_short_claim] => 50
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17998863
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/998863 | PHARMACEUTICAL COMPOSITION | May 5, 2021 | Pending |
Array
(
[id] => 17140166
[patent_doc_number] => 20210308177
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-10-07
[patent_title] => Method and Composition for Enhancing the Quality and Benefits of Sleep
[patent_app_type] => utility
[patent_app_number] => 17/244442
[patent_app_country] => US
[patent_app_date] => 2021-04-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10122
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17244442
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/244442 | Method and Composition for Enhancing the Quality and Benefits of Sleep | Apr 28, 2021 | Abandoned |
Array
(
[id] => 18404588
[patent_doc_number] => 20230165939
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-06-01
[patent_title] => SOLID COMPOSITIONS COMPRISING A GLP-1 AGONIST AND HISTIDINE
[patent_app_type] => utility
[patent_app_number] => 17/921996
[patent_app_country] => US
[patent_app_date] => 2021-04-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13342
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -10
[patent_words_short_claim] => 20
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17921996
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/921996 | SOLID COMPOSITIONS COMPRISING A GLP-1 AGONIST AND HISTIDINE | Apr 27, 2021 | Pending |
Array
(
[id] => 19737259
[patent_doc_number] => 12214068
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-02-04
[patent_title] => Methods and compositions for treating damaged hair
[patent_app_type] => utility
[patent_app_number] => 17/240839
[patent_app_country] => US
[patent_app_date] => 2021-04-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 23271
[patent_no_of_claims] => 32
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 23
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17240839
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/240839 | Methods and compositions for treating damaged hair | Apr 25, 2021 | Issued |
Array
(
[id] => 17004541
[patent_doc_number] => 20210235702
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-08-05
[patent_title] => ANTIVIRAL AGENT, COATING COMPOSITION, RESIN COMPOSITION AND ANTIVIRAL PRODUCT
[patent_app_type] => utility
[patent_app_number] => 17/238281
[patent_app_country] => US
[patent_app_date] => 2021-04-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10677
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 67
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17238281
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/238281 | Antiviral agent, coating composition, resin composition and antiviral product | Apr 22, 2021 | Issued |
Array
(
[id] => 17235475
[patent_doc_number] => 11179338
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2021-11-23
[patent_title] => Powder for oral suspension containing tadalafil
[patent_app_type] => utility
[patent_app_number] => 17/237319
[patent_app_country] => US
[patent_app_date] => 2021-04-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 3
[patent_no_of_words] => 7354
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 244
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17237319
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/237319 | Powder for oral suspension containing tadalafil | Apr 21, 2021 | Issued |
Array
(
[id] => 17168027
[patent_doc_number] => 20210321697
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-10-21
[patent_title] => ANTIMICROBIAL UV-C EMITTING COMPOSITION FOR MASKS AND RELATED DEVICES AND METHODS
[patent_app_type] => utility
[patent_app_number] => 17/232965
[patent_app_country] => US
[patent_app_date] => 2021-04-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8292
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -22
[patent_words_short_claim] => 31
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17232965
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/232965 | Antimicrobial UV-C emitting composition for masks and related devices and methods | Apr 15, 2021 | Issued |
Array
(
[id] => 20142735
[patent_doc_number] => 12377050
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-08-05
[patent_title] => Methods of forming particles by continuous droplet formation and dehydration
[patent_app_type] => utility
[patent_app_number] => 17/916618
[patent_app_country] => US
[patent_app_date] => 2021-04-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 13
[patent_no_of_words] => 34834
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 182
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17916618
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/916618 | Methods of forming particles by continuous droplet formation and dehydration | Apr 15, 2021 | Issued |
Array
(
[id] => 17927567
[patent_doc_number] => 20220322692
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-10-13
[patent_title] => STEM CELL BOOSTING CHOCOLATE COMPOSITION
[patent_app_type] => utility
[patent_app_number] => 17/226030
[patent_app_country] => US
[patent_app_date] => 2021-04-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3291
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 76
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17226030
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/226030 | Stem cell boosting chocolate composition | Apr 7, 2021 | Issued |